When therapy-sensitive cancer cells die, they release a ‘killer peptide’ that can eliminate therapy-resistant cells, new research indicates.
When therapy-sensitive cancer cells die, they release a ‘killer peptide’ that can eliminate therapy-resistant cells, new research indicates.